Skip to main content

Table 1 Cell type specific markers reveal consistent multicellular components of the biopsies

From: Molecular Markers in Patients with Chronic Wounds to Guide Surgical Debridement

Wound biopsy

Vimentin (VIM)

Perlecan (HSPG2)

Stratifin (SFN)

Junctional plakoglobin (JUP)

Location A

0.36785

0.893798

0.50650

0.52979

Location A

0.39184

0.935004

0.40537

0.55427

Location A

0.32949

0.690294

0.49262

0.55113

Location B

0.24775

0.707999

0.44484

0.56766

Location B

0.23126

0.803647

0.42237

0.53427

Location Ba

0.24300

0.921853

0.47479

0.57156

  1. Signal intensity normalized to the chip for vimentin, perlecan, stratifin and junctional plakoglobin are shown for each biopsy and particular location. Overall, no considerable changes in the levels of perlecan, stratifin and junctional plakoglobin are found. Vimentin expression is regulated between two locations, but the level of expression is consistent within each group supporting consistent biopsy procedure.
  2. a Biopsy from presumed location B, actual location A, from patient 3 (see Figure 5A).
Back to article page

Molecular Medicine

ISSN: 1528-3658